Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyMolecularFunctionmRNA 3'-UTR binding

SYNCRIP HNRNPR

5.05e-0327682GO:0003730
GeneOntologyCellularComponentcollagen trimer

COL24A1 LOX

4.83e-048882GO:0005581
GeneOntologyCellularComponentcatalytic step 2 spliceosome

SYNCRIP HNRNPR

5.86e-049782GO:0071013
GeneOntologyCellularComponentspliceosomal complex

SYNCRIP HNRNPR

2.83e-0321582GO:0005681
MousePhenoatelectasis

MRAP LOX

1.21e-0310872MP:0001177
MousePhenoabnormal lung development

MRAP LOX

2.08e-0314272MP:0001176
MousePhenoabnormal respiratory system development

MRAP LOX

2.63e-0316072MP:0003115
DomainHnRNP_R/Q_splicing_fac

SYNCRIP HNRNPR

1.60e-06582IPR006535
DomainRRM_1

SYNCRIP HNRNPR

3.31e-0320882PF00076
DomainRRM

SYNCRIP HNRNPR

3.59e-0321782SM00360
DomainRRM_dom

SYNCRIP HNRNPR

3.92e-0322782IPR000504
DomainRRM

SYNCRIP HNRNPR

4.03e-0323082PS50102
Domain-

SYNCRIP HNRNPR

4.52e-03244823.30.70.330
DomainNucleotide-bd_a/b_plait

SYNCRIP HNRNPR

5.04e-0325882IPR012677
PathwayREACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES

COL24A1 LOX

2.73e-046162M27103
PathwayREACTOME_COLLAGEN_FORMATION

COL24A1 LOX

5.95e-049062M631
PathwayREACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION

COL24A1 LOX

6.40e-0330062M610
PathwayWP_MRNA_PROCESSING

SYNCRIP HNRNPR

1.41e-0245162MM15946
Pubmed

Heterogeneous nuclear ribonucleoproteins R and Q accumulate in pathological inclusions in FTLD-FUS.

SYNCRIP HNRNPR

1.39e-0738230755280
Pubmed

SMN interacts with a novel family of hnRNP and spliceosomal proteins.

SYNCRIP HNRNPR

2.78e-0748211574476
Pubmed

Specific interaction of Smn, the spinal muscular atrophy determining gene product, with hnRNP-R and gry-rbp/hnRNP-Q: a role for Smn in RNA processing in motor axons?

SYNCRIP HNRNPR

2.78e-0748211773003
Pubmed

Identification of a heterogeneous nuclear ribonucleoprotein-recognition region in the HIV Rev protein.

SYNCRIP HNRNPR

1.30e-0688219808671
Pubmed

Identification of methylated proteins by protein arginine N-methyltransferase 1, PRMT1, with a new expression cloning strategy.

SYNCRIP HNRNPR

1.30e-0688212183049
Pubmed

SYNCRIP, a cytoplasmic counterpart of heterogeneous nuclear ribonucleoprotein R, interacts with ubiquitous synaptotagmin isoforms.

SYNCRIP HNRNPR

2.54e-06118210734137
Pubmed

RNF125 attenuates hepatocellular carcinoma progression by downregulating SRSF1-ERK pathway.

SYNCRIP HNRNPR

2.54e-06118237142680
Pubmed

The activity of the spinal muscular atrophy protein is regulated during development and cellular differentiation.

SYNCRIP HNRNPR

3.05e-06128216236758
Pubmed

A receptor for activated C kinase is part of messenger ribonucleoprotein complexes associated with polyA-mRNAs in neurons.

SYNCRIP HNRNPR

6.29e-06178212388589
Pubmed

Interactome analyses revealed that the U1 snRNP machinery overlaps extensively with the RNAP II machinery and contains multiple ALS/SMA-causative proteins.

TASOR SYNCRIP HNRNPR

1.86e-052448329884807
Pubmed

Molecular composition of IMP1 ribonucleoprotein granules.

SYNCRIP HNRNPR

2.91e-05368217289661
Pubmed

PRP19 transforms into a sensor of RPA-ssDNA after DNA damage and drives ATR activation via a ubiquitin-mediated circuitry.

SYNCRIP HNRNPR MYO1F

5.00e-053408324332808
Pubmed

Identification of DeltaNp63alpha protein interactions by mass spectrometry.

SYNCRIP HNRNPR

5.19e-05488220085233
Pubmed

TRIM24 is an insulin-responsive regulator of P-bodies.

SYNCRIP HNRNPR

1.45e-04808235803934
Pubmed

Purification and characterization of native spliceosomes suitable for three-dimensional structural analysis.

SYNCRIP HNRNPR

1.45e-04808211991638
Pubmed

Nuclear heterogeneous nuclear ribonucleoprotein D is associated with poor prognosis and interactome analysis reveals its novel binding partners in oral cancer.

SYNCRIP HNRNPR

1.75e-04888226318153
Pubmed

DBIRD complex integrates alternative mRNA splicing with RNA polymerase II transcript elongation.

SYNCRIP HNRNPR

1.79e-04898222446626
Pubmed

Cleavage and polyadenylation specificity factor 1 (CPSF1) regulates alternative splicing of interleukin 7 receptor (IL7R) exon 6.

SYNCRIP HNRNPR

1.84e-04908223151878
Pubmed

Blocking PPARĪ³ interaction facilitates Nur77 interdiction of fatty acid uptake and suppresses breast cancer progression.

SYNCRIP HNRNPR

1.84e-04908233087562
Pubmed

Cullin-3/KCTD10 complex is essential for K27-polyubiquitination of EIF3D in human hepatocellular carcinoma HepG2 cells.

SYNCRIP HNRNPR

1.84e-04908231280863
Pubmed

Arginine methylation and ubiquitylation crosstalk controls DNA end-resection and homologous recombination repair.

TASOR SYNCRIP HNRNPR

2.09e-045518334728620
InteractionALG13 interactions

SYNCRIP HNRNPR LOX

3.99e-0518383int:ALG13
InteractionRNF125 interactions

SYNCRIP HNRNPR

1.88e-045382int:RNF125
InteractionZNF169 interactions

SYNCRIP HNRNPR

1.95e-045482int:ZNF169
InteractionPAIP2 interactions

SYNCRIP HNRNPR

2.66e-046382int:PAIP2
InteractionMIR138-1 interactions

SYNCRIP HNRNPR

3.10e-046882int:MIR138-1
InteractionMIR9-3 interactions

SYNCRIP HNRNPR

3.29e-047082int:MIR9-3
InteractionMIR29B2 interactions

SYNCRIP HNRNPR

3.38e-047182int:MIR29B2
InteractionMIR140 interactions

SYNCRIP HNRNPR

3.38e-047182int:MIR140
InteractionMIR122 interactions

SYNCRIP HNRNPR

3.38e-047182int:MIR122
InteractionMIR29B1 interactions

SYNCRIP HNRNPR

3.57e-047382int:MIR29B1
InteractionMIR18A interactions

SYNCRIP HNRNPR

3.57e-047382int:MIR18A
InteractionMIR20A interactions

SYNCRIP HNRNPR

3.67e-047482int:MIR20A
InteractionMIR15A interactions

SYNCRIP HNRNPR

3.77e-047582int:MIR15A
InteractionMIR429 interactions

SYNCRIP HNRNPR

3.87e-047682int:MIR429
InteractionMIR16-1 interactions

SYNCRIP HNRNPR

3.87e-047682int:MIR16-1
InteractionMIR7-3 interactions

SYNCRIP HNRNPR

3.87e-047682int:MIR7-3
InteractionMIR199A2 interactions

SYNCRIP HNRNPR

3.87e-047682int:MIR199A2
InteractionMIR9-2 interactions

SYNCRIP HNRNPR

3.97e-047782int:MIR9-2
InteractionMIR200A interactions

SYNCRIP HNRNPR

3.97e-047782int:MIR200A
InteractionMIR451A interactions

SYNCRIP HNRNPR

4.08e-047882int:MIR451A
InteractionMIR98 interactions

SYNCRIP HNRNPR

4.08e-047882int:MIR98
InteractionMIR92A1 interactions

SYNCRIP HNRNPR

4.08e-047882int:MIR92A1
InteractionMIR222 interactions

SYNCRIP HNRNPR

4.18e-047982int:MIR222
InteractionMIR206 interactions

SYNCRIP HNRNPR

4.18e-047982int:MIR206
InteractionMIR34C interactions

SYNCRIP HNRNPR

4.18e-047982int:MIR34C
InteractionMIR1-2 interactions

SYNCRIP HNRNPR

4.18e-047982int:MIR1-2
InteractionMIR143 interactions

SYNCRIP HNRNPR

4.29e-048082int:MIR143
InteractionKIF20A interactions

SYNCRIP HNRNPR MYO1F LOX

4.36e-04105284int:KIF20A
InteractionMIR145 interactions

SYNCRIP HNRNPR

4.40e-048182int:MIR145
InteractionMIR10B interactions

SYNCRIP HNRNPR

4.51e-048282int:MIR10B
InteractionMIR106A interactions

SYNCRIP HNRNPR

4.62e-048382int:MIR106A
InteractionMIR200B interactions

SYNCRIP HNRNPR

4.73e-048482int:MIR200B
InteractionMIR7-2 interactions

SYNCRIP HNRNPR

4.73e-048482int:MIR7-2
InteractionMIR31 interactions

SYNCRIP HNRNPR

4.73e-048482int:MIR31
InteractionMIR199A1 interactions

SYNCRIP HNRNPR

4.73e-048482int:MIR199A1
InteractionMIR16-2 interactions

SYNCRIP HNRNPR

4.84e-048582int:MIR16-2
InteractionMIR93 interactions

SYNCRIP HNRNPR

4.84e-048582int:MIR93
InteractionMIR9-1 interactions

SYNCRIP HNRNPR

4.84e-048582int:MIR9-1
InteractionMIR107 interactions

SYNCRIP HNRNPR

4.84e-048582int:MIR107
InteractionMIR17 interactions

SYNCRIP HNRNPR

4.84e-048582int:MIR17
InteractionMIR18B interactions

SYNCRIP HNRNPR

4.84e-048582int:MIR18B
InteractionMIR20B interactions

SYNCRIP HNRNPR

4.96e-048682int:MIR20B
InteractionMIR29A interactions

SYNCRIP HNRNPR

5.07e-048782int:MIR29A
InteractionMIR141 interactions

SYNCRIP HNRNPR

5.19e-048882int:MIR141
InteractionMIR138-2 interactions

SYNCRIP HNRNPR

5.19e-048882int:MIR138-2
InteractionMIR29C interactions

SYNCRIP HNRNPR

5.31e-048982int:MIR29C
InteractionSNRPC interactions

TASOR SYNCRIP HNRNPR

5.33e-0444083int:SNRPC
InteractionMIR221 interactions

SYNCRIP HNRNPR

5.43e-049082int:MIR221
InteractionMIR92A2 interactions

SYNCRIP HNRNPR

5.43e-049082int:MIR92A2
InteractionMIR1-1 interactions

SYNCRIP HNRNPR

5.43e-049082int:MIR1-1
InteractionMIR200C interactions

SYNCRIP HNRNPR

5.55e-049182int:MIR200C
InteractionMIR128-1 interactions

SYNCRIP HNRNPR

5.67e-049282int:MIR128-1
InteractionMIR155 interactions

SYNCRIP HNRNPR

5.67e-049282int:MIR155
InteractionMIR214 interactions

SYNCRIP HNRNPR

5.79e-049382int:MIR214
InteractionMIR205 interactions

SYNCRIP HNRNPR

5.79e-049382int:MIR205
InteractionMIR19B2 interactions

SYNCRIP HNRNPR

5.92e-049482int:MIR19B2
InteractionKHDRBS3 interactions

SYNCRIP HNRNPR

5.92e-049482int:KHDRBS3
InteractionMIRLET7F1 interactions

SYNCRIP HNRNPR

5.92e-049482int:MIRLET7F1
InteractionMIRLET7A2 interactions

SYNCRIP HNRNPR

6.17e-049682int:MIRLET7A2
InteractionMIRLET7C interactions

SYNCRIP HNRNPR

6.30e-049782int:MIRLET7C
InteractionMIR21 interactions

SYNCRIP HNRNPR

6.30e-049782int:MIR21
InteractionMIRLET7F2 interactions

SYNCRIP HNRNPR

6.30e-049782int:MIRLET7F2
InteractionMIR363 interactions

SYNCRIP HNRNPR

6.30e-049782int:MIR363
InteractionMIR106B interactions

SYNCRIP HNRNPR

6.43e-049882int:MIR106B
InteractionMIR128-2 interactions

SYNCRIP HNRNPR

6.56e-049982int:MIR128-2
InteractionMIR19A interactions

SYNCRIP HNRNPR

6.69e-0410082int:MIR19A
InteractionMIRLET7B interactions

SYNCRIP HNRNPR

6.83e-0410182int:MIRLET7B
InteractionMIRLET7D interactions

SYNCRIP HNRNPR

6.83e-0410182int:MIRLET7D
InteractionMIR25 interactions

SYNCRIP HNRNPR

6.83e-0410182int:MIR25
InteractionSNRPA interactions

TASOR SYNCRIP HNRNPR

6.96e-0448283int:SNRPA
InteractionMIRLET7A3 interactions

SYNCRIP HNRNPR

6.96e-0410282int:MIRLET7A3
InteractionMIR7-1 interactions

SYNCRIP HNRNPR

7.10e-0410382int:MIR7-1
InteractionMIR15B interactions

SYNCRIP HNRNPR

7.10e-0410382int:MIR15B
InteractionPRMT8 interactions

SYNCRIP HNRNPR

7.24e-0410482int:PRMT8
InteractionMIR34A interactions

SYNCRIP HNRNPR

7.24e-0410482int:MIR34A
InteractionMIR19B1 interactions

SYNCRIP HNRNPR

7.24e-0410482int:MIR19B1
InteractionMIRLET7E interactions

SYNCRIP HNRNPR

7.52e-0410682int:MIRLET7E
InteractionMIRLET7A1 interactions

SYNCRIP HNRNPR

7.80e-0410882int:MIRLET7A1
InteractionMIR34B interactions

SYNCRIP HNRNPR

8.09e-0411082int:MIR34B
InteractionSNRPB interactions

TASOR SYNCRIP HNRNPR

8.54e-0451783int:SNRPB
InteractionSMN2 interactions

SYNCRIP HNRNPR

8.69e-0411482int:SMN2
InteractionMIRLET7I interactions

SYNCRIP HNRNPR

8.69e-0411482int:MIRLET7I
InteractionCPSF6 interactions

TASOR SYNCRIP HNRNPR

8.98e-0452683int:CPSF6
InteractionMIRLET7G interactions

SYNCRIP HNRNPR

9.15e-0411782int:MIRLET7G
InteractionSCARNA22 interactions

SYNCRIP HNRNPR

9.30e-0411882int:SCARNA22
InteractionKHDRBS2 interactions

SYNCRIP HNRNPR

1.11e-0312982int:KHDRBS2
InteractionUBE2S interactions

SYNCRIP HNRNPR

1.27e-0313882int:UBE2S
InteractionACSL4 interactions

SYNCRIP HNRNPR

1.31e-0314082int:ACSL4
InteractionIL7R interactions

SYNCRIP HNRNPR

1.32e-0314182int:IL7R
InteractionDAZL interactions

SYNCRIP HNRNPR

1.40e-0314582int:DAZL
InteractionCPEB1 interactions

SYNCRIP HNRNPR

1.42e-0314682int:CPEB1
InteractionAPOBEC3D interactions

SYNCRIP HNRNPR

1.46e-0314882int:APOBEC3D
InteractionHNRNPC interactions

NAP1L2 SYNCRIP HNRNPR

1.54e-0363483int:HNRNPC
InteractionFBL interactions

NAP1L2 SYNCRIP HNRNPR

1.58e-0363983int:FBL
InteractionMATR3 interactions

TASOR SYNCRIP HNRNPR

1.69e-0365583int:MATR3
InteractionMORF4L2 interactions

SYNCRIP HNRNPR

1.87e-0316882int:MORF4L2
InteractionSSRP1 interactions

TASOR SYNCRIP HNRNPR

1.93e-0368583int:SSRP1
GeneFamilyRNA binding motif containing

SYNCRIP HNRNPR

8.16e-0421342725
ToppCellTCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Mucinous_Colon_Adenocarcinoma-10|TCGA-Colorectal / Sample_Type by Project: Shred V9

COL24A1 MYO1F LOX

3.42e-0617983cc079ba015326dccde955c5eafa3e4a2e40de192
ToppCellGlobus_pallidus-Macroglia-POLYDENDROCYTE-P3|Globus_pallidus / BrainAtlas - Mouse McCarroll V32

SYNCRIP HNRNPR

1.55e-0410782c41bc8810df67158f0ae9f6015c965a8ebd96965
ToppCellGlobus_pallidus-Macroglia-POLYDENDROCYTE-P3-Tnr|Globus_pallidus / BrainAtlas - Mouse McCarroll V32

SYNCRIP HNRNPR

1.55e-041078260b272f5c89bea8a2714f870e18b7ac89a4a4bf6
ToppCellHippocampus-Endothelial-MURAL-M1(Rgs5Acta2)-M1_3-MURAL_Mural.Rgs5Acta2.Col3a1_(Mural.Rgs5Acta2.Col3a1)|Hippocampus / BrainAtlas - Mouse McCarroll V32

MRAP LOX

2.44e-041348222c64b8c405f3752331b81c611d8e62bd58c07f7
ToppCellHippocampus-Endothelial-MURAL-M1(Rgs5Acta2)-M1_3-MURAL_Mural.Rgs5Acta2.Col3a1_(Mural.Rgs5Acta2.Col3a1)-|Hippocampus / BrainAtlas - Mouse McCarroll V32

MRAP LOX

2.44e-04134829a9fa63b40d9bf94995d70ef19d2548cb418b138
ToppCellHippocampus-Macroglia-POLYDENDROCYTE-P5-P5_2|Hippocampus / BrainAtlas - Mouse McCarroll V32

SYNCRIP HNRNPR

2.51e-04136823e13dc0634f3b05e9f9e6c3193f843f62e603b78
ToppCellHippocampus-Macroglia-POLYDENDROCYTE-P5-P5_2-Sox4|Hippocampus / BrainAtlas - Mouse McCarroll V32

SYNCRIP HNRNPR

2.51e-04136820185486c39700dd2f72d79be6d283494dd8379c9
ToppCell367C-Lymphocytic-NK_cells-NK_cell_E|367C / Donor, Lineage, Cell class and subclass (all cells)

NAP1L2 COL24A1

3.01e-0414982f18bddc84b064f3d57a1281d5172c404d87f25da
ToppCelldroplet-Fat-Scat-21m-Myeloid-monocyte|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation

NAP1L2 MYO1F

3.05e-0415082b6e5e04aaf1c5265ac07581868d3159f9292a84c
ToppCellGlobus_pallidus-Macroglia-POLYDENDROCYTE-P3-Tnr-Polydendrocyte.Tnr.Cyth3_(Cyth3)|Globus_pallidus / BrainAtlas - Mouse McCarroll V32

SYNCRIP HNRNPR

3.17e-041538288ca2d2c2ab19fbee13e18951b993ee05dd30f67
ToppCellGlobus_pallidus-Macroglia-POLYDENDROCYTE-P3-Tnr-Polydendrocyte.Tnr.Cyth3_(Cyth3)-|Globus_pallidus / BrainAtlas - Mouse McCarroll V32

SYNCRIP HNRNPR

3.17e-0415382553dff9688a1996d8f4ba16e60c683593d781389
ToppCelldroplet-Liver-LIVER_NPC-30m-Myeloid-macrophage/monocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

NAP1L2 MYO1F

3.47e-04160828dae9b0cf90a09acb196223f45a14680102630b2
ToppCellfacs-Brain_Myeloid-Cerebellum_-18m|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

MYO1F LOX

3.51e-0416182b14a83ad07a7acb07c766aa862b527698976b6fc
ToppCellfacs-Brain_Myeloid-Cerebellum_|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

MYO1F LOX

3.51e-04161825c762609531a7c5505aa5637abf8e0311568d7fd
ToppCellfacs-Brain_Myeloid-Cerebellum_-18m-Myeloid|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

MYO1F LOX

3.51e-0416182c5d9d47dcedfbb1ac77f4afaf860ae4d9f26fd3f
ToppCellfacs-Brain_Myeloid-Cerebellum_-18m-Myeloid-nan|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

MYO1F LOX

3.51e-041618226c0d876339bfd34d9a43af5b9fb08f50526f2c9
ToppCelldroplet-Limb_Muscle-nan-18m-Myeloid-chondrocyte-like|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

MYO1F LOX

3.56e-041628271d7849108a1b59beff40e46000172c45a2f5439
ToppCellE16.5-samps-Mesenchymal-Matrix_fibroblast-_fetal-Mature_Fibroblast_1|E16.5-samps / Age Group, Lineage, Cell class and subclass

MRAP LOX

3.60e-0416382f1ec2625b52664308968b01d8e0275e1e0751480
ToppCelldroplet-Kidney-nan-24m-Myeloid-CD45____macrophage|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

MRAP MYO1F

3.64e-0416482d57faa4fce1f1e9a92aaf5cb920af99323252e4b
ToppCelldroplet-Kidney-nan-24m-Myeloid-macrophage|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

MRAP MYO1F

3.64e-0416482d0b6c29e61d15f4dbe4c1f6e5ed3e10f41f820ab
ToppCelldroplet-Kidney-nan-24m-Myeloid|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

MRAP MYO1F

3.64e-0416482718cc64b7ef7d03d095be4b2b54c449154da568c
ToppCellE16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

COL24A1 LOX

3.69e-04165824e13fccd32029e2879e85f8966e582a46c09e4aa
ToppCellfacs-Brain_Myeloid-Cerebellum_-18m-Myeloid-microglial_cell|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

MYO1F LOX

3.73e-04166824ab1959c526c2fd83077fc03e4de207f34841a19
ToppCellPND28-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

MRAP LOX

3.78e-04167825fc85a05124cd2324e1b8ff940193880f83cd8af
ToppCellPND28-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

MRAP LOX

3.78e-0416782f01b96173deda0239fa482989873cf308e49d48c
ToppCellE16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

COL24A1 LOX

3.78e-0416782fe3338f99f94c0dac37e3d649dfdce82e4a56022
ToppCellfacs-Lung-3m-Hematologic-myeloid-myeloid_dendritic_cell-myeloid_dendritic_type_1|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

NAP1L2 MYO1F

3.78e-0416782fd84a99ea142d1684cdcf4a88ef1d541760bc78a
ToppCell3'-Child09-12-SmallIntestine-Hematopoietic-T_cells-TRGV5/7_gdT|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

NAP1L2 MYO1F

3.82e-0416882235c368669c017e13a7312fce3d8b91d7d106c7a
ToppCellPND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

COL24A1 LOX

3.87e-0416982335619507857383c3b0b507cdf05d786ed59e585
ToppCellP15-Mesenchymal-mesenchymal_fibroblast-mesenchymal_progenitor_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase

MRAP LOX

3.92e-0417082ba4ba66b624089ed50a9083176386c7941b4c7a3
ToppCellE17.5-Mesenchymal-developing_mesenchymal_cell-mesenchymal_immature_unknown_1|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase

NAP1L2 LOX

3.92e-04170827fa022471e14ac8a3bc147c793368a4d56a8e591
ToppCell3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

COL24A1 LOX

4.15e-04175821799a7be623dc3bf53ba580a7c47d2619969d708
ToppCelltumor_Lymph_Node_/_Brain-Fibroblasts-COL13A1+_matrix_FBs|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass

MRAP LOX

4.20e-0417682510f9a14dc1c151d24d079e0cc004cdf4f86336c
ToppCellrenal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

COL24A1 LOX

4.24e-04177829ec7f1e64312d26d434b3312b58386715dbad644
ToppCellPND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_G2M|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

COL24A1 LOX

4.24e-04177824197cf2b1e743230c821f422836fa5991b155a52
ToppCellrenal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

COL24A1 LOX

4.24e-0417782016277dfd59b1793fddaaadc2b3f41622d76ce3a
ToppCellsystemic_lupus_erythematosus-treated-Hematopoietic-progenitor_cell-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex

COL24A1 LOX

4.39e-0418082ef0de602fc8ccfd32a06978ac0100afe0ce1beeb
ToppCellHippocampus-Macroglia-POLYDENDROCYTE-P5|Hippocampus / BrainAtlas - Mouse McCarroll V32

SYNCRIP HNRNPR

4.39e-041808244988c34861df359a68376500c42a64fbcc4b431
ToppCellsystemic_lupus_erythematosus-treated-Hematopoietic-progenitor_cell|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex

COL24A1 LOX

4.39e-04180822694f5deaed551c53e74d8a9fbd41d3734bb9f37
ToppCellTCGA-Thryoid-Primary_Tumor-Thyroid_Papillary_Carcinoma-Classical-1|TCGA-Thryoid / Sample_Type by Project: Shred V9

COL24A1 LOX

4.53e-041838206e4b05d86a7d643569e19575c2c9aa351d33f29
ToppCell3'-Adult-LargeIntestine-Hematopoietic-T_cells-ILC3|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

COL24A1 MYO1F

4.58e-04184822f9c5887635185dc1c6ec4e959b6d8a28b0bd020
ToppCell3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

MRAP LOX

4.58e-04184824a9f798c67b9998bffe44242b210cc1e224ff5b1
ToppCellILEUM-inflamed-(3)_MNP-(3)_moDC|(3)_MNP / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)

MRAP MYO1F

4.73e-04187820099def970fbc828756fbf853eca2ce77b8cd342
ToppCellMonocytes-Donor_08|World / lung cells shred on cell class, cell subclass, sample id

MRAP MYO1F

4.78e-0418882756375cf9c9cccc4fb4a7f5e4756fa3fc36a7892
ToppCellHippocampus-Macroglia-POLYDENDROCYTE|Hippocampus / BrainAtlas - Mouse McCarroll V32

SYNCRIP HNRNPR

4.78e-04188828bd6f2cd1aadbd6f9ed31b160f59c1eff144e1dc
ToppCellMesenchymal_cells-Osteoblasts|World / Lineage and Cell class

COL24A1 LOX

4.78e-041888289f7f5a51be7e046a63e2413f86c521ae4b6718f
ToppCell10x_3'_v3-lymph_node_(10x_3'_v3)-lymphocytic-innate_lymphocytic-mature_NK_T_cell|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

COL24A1 MYO1F

4.99e-0419282df4741e7684f010445f0224a1fd61aaa4fae02b3
ToppCell10x3'2.3-week_17-19-Mesenchymal_osteo-stroma-osteoblast|week_17-19 / cell types per 3 fetal stages;per 3',per 5'

COL24A1 LOX

5.09e-0419482811b382ec3da06a6bda7360abc8b633f96b2019e
ToppCellILEUM-inflamed-(3)_moDC|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)

MRAP MYO1F

5.09e-0419482c9d2acab0bbcfa9a9113cf3b9f8147403f0beb43
ToppCellE17.5-Mesenchymal-mesenchymal_fibroblast|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase

MRAP LOX

5.09e-0419482f15e81ff12525523c62d13105cf264ea72205e2e
ToppCell10x5'v1-week_14-16-Mesenchymal_osteo-stroma-osteoblast|week_14-16 / cell types per 3 fetal stages;per 3',per 5'

COL24A1 LOX

5.09e-0419482292ce9021678534c9eedb367b9772a9d976208a8
ToppCellE18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

COL24A1 LOX

5.14e-0419582a486a7acea0e91048cc48afa0dbd3926d30bc217
ToppCellE18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

COL24A1 LOX

5.14e-0419582b0d408f8bc1701a87596ed55efcd90749fee33e6
ToppCellE17.5-Mesenchymal-mesenchymal_fibroblast-alveolar_fibroblast_Wnt2-pa|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase

MRAP LOX

5.14e-0419582b072fdc2131173f562e55dd78226eaf2c57d3690
ToppCellILEUM-non-inflamed-(3)_moDC|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)

MRAP MYO1F

5.20e-0419682e10f01172fd076d6892906853f9375d4c3058951
ToppCell10x5'v1-week_17-19-Mesenchymal_osteo-stroma-osteoblast|week_17-19 / cell types per 3 fetal stages;per 3',per 5'

COL24A1 LOX

5.20e-0419682d5ed41fa111750e6b363c04cccc40a47dd774852
ToppCellDendritic_cell|World / shred by cell class for turbinate

MRAP MYO1F

5.25e-0419782ab2213e3742f92798922ea318d76328b6ca18b13
ToppCellLAM-Endothelial-LymEndo|Endothelial / Condition, Lineage and Cell class

SYNCRIP LOX

5.30e-0419882ba64b1c95dfaa995045239d412e725596f6c482e
ToppCellMegakaryocytic-erythropoietic-Erythro-cells-Basophilic_Erythroblast|Megakaryocytic-erythropoietic / Lineage, cell class and subclass

SYNCRIP HNRNPR

5.36e-04199826f159c1215439ec22374903124085746fa8da333
ToppCellBiopsy_Control_(H.)-Mesenchymal-Myofibroblasts|Biopsy_Control_(H.) / Sample group, Lineage and Cell type

MRAP LOX

5.36e-04199827a227c239afdaebcac84644d9b2653a5f1a4be71
ToppCellLung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-3|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)

MRAP COL24A1

5.41e-042008207641f476cb1a131c2a50258b88cc13bb38c8379
ToppCellParenchyma_Control_(B.)-Stromal-TX-Fibroblasts-3|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type

MRAP COL24A1

5.41e-0420082343fa6ba1f52d816d2e41466f674ff8360aecd81
ToppCellcellseq-Mesenchymal-Myocytic-Myocytic_2-SCMF|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

COL24A1 LOX

5.41e-0420082b441b3771fb7d9ee7b7a104afc35e466aace2da2
ToppCellLung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-3-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

MRAP COL24A1

5.41e-0420082d0c00cdd52c2e001aec9b935f4e981ba77d0386a
ComputationalNeighborhood of DENR

SYNCRIP HNRNPR

2.19e-045152GNF2_DENR
ComputationalNeighborhood of SMC1L1

SYNCRIP HNRNPR

3.24e-046252MORF_SMC1L1
ComputationalNeighborhood of KPNB1

SYNCRIP HNRNPR

4.49e-047352GNF2_KPNB1
ComputationalNeighborhood of APEX1

SYNCRIP HNRNPR

7.13e-049252GNF2_APEX1
ComputationalNeighborhood of FBL

SYNCRIP HNRNPR

1.78e-0314652GNF2_FBL
ComputationalNeighborhood of MYST2

SYNCRIP HNRNPR

2.47e-0317252GCM_MYST2
DrugBAPN

COL24A1 LOX

2.65e-047182CID000001647
Drughydroxylysine

COL24A1 LOX

6.24e-0410982CID000001029
Drugbromovanin

SYNCRIP HNRNPR

8.46e-0412782ctd:C515564
DrugAC1OCADI

SYNCRIP HNRNPR

8.86e-0413082CID006914639
DrugDMSe

COL24A1 LOX

9.13e-0413282CID000020796
Drugchloroform

NAP1L2 MRAP

9.97e-0413882CID000006212
DrugDL-penicillamine

COL24A1 LOX

1.01e-0313982CID000004727
DrugAC1L1AUZ

SYNCRIP HNRNPR

1.29e-0315782CID000001160
DrugAC1NRA5C

SYNCRIP HNRNPR

1.58e-0317482CID005287709
DrugDigoxigenin [1672-46-4]; Down 200; 10.2uM; MCF7; HT_HG-U133A

NAP1L2 TASOR

1.67e-03179825640_DN
DrugEtoposide [33419-42-0]; Down 200; 6.8uM; HL60; HG-U133A

TASOR SYNCRIP

1.69e-03180821626_DN
DrugDigitoxigenin [143-62-4]; Down 200; 10.6uM; MCF7; HT_HG-U133A

NAP1L2 TASOR

1.71e-03181823275_DN
Druggeldanamycin; Up 200; 1uM; MCF7; HT_HG-U133A_EA

NAP1L2 MYO1F

1.72e-03182821008_UP
DrugDigitoxigenin [143-62-4]; Down 200; 10.6uM; HL60; HT_HG-U133A

TASOR SYNCRIP

1.80e-03186821339_DN
Drug17-AAG; Up 200; 1uM; PC3; HT_HG-U133A

NAP1L2 MYO1F

1.82e-03187825958_UP
DrugNocodazole [31430-18-9]; Up 200; 13.2uM; MCF7; HT_HG-U133A

TASOR LOX

1.84e-03188822239_UP
Drug12(S)-hydroxyeicosatetraenoic acid

COL24A1 LOX

1.86e-0318982CID000001413
DrugBisacodyl [603-50-9]; Down 200; 11uM; MCF7; HT_HG-U133A

NAP1L2 TASOR

1.86e-03189825677_DN
DrugThioguanosine [85-31-4]; Down 200; 12.6uM; MCF7; HT_HG-U133A

TASOR SYNCRIP

1.88e-03190822619_DN
DrugOxyphenbutazone [129-20-4]; Up 200; 12.4uM; MCF7; HT_HG-U133A

NAP1L2 MYO1F

1.88e-03190826844_UP
DrugLY 294002; Down 200; 10uM; MCF7; HT_HG-U133A_EA

TASOR SYNCRIP

1.88e-03190821074_DN
DrugSpironolactone [52-01-7]; Down 200; 9.6uM; HL60; HG-U133A

TASOR HNRNPR

1.94e-03193821380_DN
DrugCinchonine [118-10-5]; Down 200; 13.6uM; PC3; HT_HG-U133A

MYO1F LOX

1.96e-03194823988_DN
DrugTocopherol (R,S) [10191-41-0]; Up 200; 9.2uM; MCF7; HT_HG-U133A

MYO1F LOX

1.96e-03194824961_UP
Drug17-AAG; Up 200; 1uM; ssMCF7; HG-U133A

NAP1L2 MYO1F

1.98e-0319582521_UP
DrugGraveoline [485-61-0]; Down 200; 14.4uM; PC3; HT_HG-U133A

MYO1F LOX

2.00e-03196824276_DN
DrugDehydroisoandosterone 3-acetate [853-23-6]; Down 200; 12.2uM; PC3; HT_HG-U133A

MYO1F LOX

2.00e-03196826673_DN
DrugDemeclocycline hydrochloride [64-73-3]; Up 200; 8uM; MCF7; HT_HG-U133A

MYO1F LOX

2.00e-03196823604_UP
DrugDiphenhydramine hydrochloride [147-24-0]; Up 200; 13.8uM; MCF7; HT_HG-U133A

NAP1L2 MYO1F

2.00e-03196821708_UP
DrugApomorphine hydrochloride hemihydrate [41372-20-7]; Down 200; 6.4uM; HL60; HG-U133A

TASOR HNRNPR

2.00e-03196822005_DN
DrugAmiprilose hydrochloride [60414-06-4]; Up 200; 11.8uM; MCF7; HT_HG-U133A

MYO1F LOX

2.02e-03197823339_UP
Drug0175029-0000 [211245-78-2]; Down 200; 1uM; PC3; HT_HG-U133A

TASOR SYNCRIP

2.02e-03197823694_DN
Drugcobalt(II) chloride hexahydrate; Down 200; 100uM; MCF7; HG-U133A

TASOR MYO1F

2.04e-0319882383_DN
DrugDextromethorphan hydrobromide monohydrate [6700-34-1]; Up 200; 10.8uM; PC3; HT_HG-U133A

MYO1F LOX

2.04e-03198826300_UP
DrugEtoposide [33419-42-0]; Down 200; 6.8uM; PC3; HT_HG-U133A

MYO1F LOX

2.04e-03198826681_DN
DrugAztreonam [78110-38-0]; Up 200; 9.2uM; PC3; HT_HG-U133A

MYO1F LOX

2.04e-03198825110_UP
DrugRemoxipride Hydrochloride [73220-03-8]; Up 200; 9.8uM; PC3; HT_HG-U133A

MYO1F LOX

2.06e-03199826342_UP
DrugBenzonatate [104-31-4]; Up 200; 6.6uM; MCF7; HT_HG-U133A

NAP1L2 MYO1F

2.06e-03199821679_UP
DrugCyclizine hydrochloride [303-25-3]; Up 200; 13.2uM; PC3; HT_HG-U133A

MYO1F LOX

2.06e-03199825100_UP
DrugSulfameter [651-06-9]; Up 200; 14.2uM; MCF7; HT_HG-U133A

MYO1F LOX

2.06e-03199826212_UP
DrugOleandomycin phosphate [7060-74-4]; Down 200; 5uM; HL60; HG-U133A

TASOR HNRNPR

2.08e-03200822018_DN
DrugEtifenin [63245-28-3]; Up 200; 12.4uM; HL60; HT_HG-U133A

NAP1L2 LOX

2.08e-03200822477_UP
DiseaseEczema

MRAP TASOR

2.23e-0331072HP_0000964
Diseasecorneal resistance factor

COL24A1 LOX

4.65e-0345172EFO_0010067
Diseaseintraocular pressure measurement

COL24A1 LOX

5.89e-0350972EFO_0004695
Diseasebody surface area

TASOR COL24A1

9.26e-0364372EFO_0022196
Diseasemonocyte percentage of leukocytes

HNRNPR MYO1F

1.18e-0273172EFO_0007989
DiseaseLiver Cirrhosis, Experimental

MYO1F LOX

1.32e-0277472C0023893
Diseasesexual dimorphism measurement

TASOR MYO1F

2.60e-02110672EFO_0021796

Protein segments in the cluster

PeptideGeneStartEntry
YVDEDDGYEDYYYDY

NAP1L2

196

Q9ULW6
YGYEDYYDYYGYDYH

SYNCRIP

461

O60506
GYEDYYDDYYGYDYH

HNRNPR

466

O43390
KYSDDNPYYNYYDTY

LOX

176

P28300
YYSYEYYLDYLDLIP

MRAP

11

Q8TCY5
AYRAYELTQYYFYEY

TASOR

291

Q9UK61
IENSYETELYDYYYY

COL24A1

461

Q17RW2
ETELYDYYYYEDLNT

COL24A1

466

Q17RW2
DYYYYLNQSDTYQVD

MYO1F

231

O00160